SCHEMBL1284982

SCHEMBL1284982

CCOCc1cc2ccc(OC)cc2oc1=O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR55 Q9Y2T6 2/20 0.62
ALDH1A1 P00352 5/20 0.57
KDM4E B2RXH2 5/20 0.57
HPGD P15428 4/20 0.57
MAOB P27338 4/20 0.57
GLA P06280 4/20 0.57
GAA P10253 4/20 0.57
CA12 O43570 3/20 0.57
CA9 Q16790 3/20 0.57
CA2 P00918 2/20 0.57
CA3 P07451 2/20 0.57
CA4 P22748 2/20 0.57
CA6 P23280 2/20 0.57
CA7 P43166 2/20 0.57
CA14 Q9ULX7 2/20 0.57
CYP19A1 P11511 1/20 0.55
CYP2C19 P33261 1/20 0.54
LGALS9 O00182 1/20 0.53
LGALS8 O00214 1/20 0.53
LGALS1 P09382 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12523188 0.87 GPR55 (0.70) GPR55ALDH1A1KDM4EHPGDMAOB
SCHEMBL1284980 0.82 MAOB (0.64) GPR55MAOBCA12CA9CA2
SCHEMBL7513873 0.81 GPR55 (0.67) GPR55ALDH1A1KDM4EHPGDMAOB
SCHEMBL11618512 0.81 GPR55 (0.67) GPR55ALDH1A1KDM4EHPGDMAOB
SCHEMBL1284769 0.80 MAOB (0.57) ALDH1A1KDM4EHPGDMAOBCA12
SCHEMBL27221219 0.79 GPR55 (0.64) GPR55ALDH1A1KDM4EHPGDMAOB
SCHEMBL2689001 0.78 GPR55 (0.62) GPR55ALDH1A1KDM4EHPGDMAOB
SCHEMBL21121524 0.78 GPR55 (0.66) GPR55ALDH1A1KDM4EHPGDMAOB
SCHEMBL5464496 0.77 GPR55 (0.61) GPR55ALDH1A1KDM4EHPGDMAOB
SCHEMBL1284893 0.76 NPC1 (0.57) GPR55ALDH1A1KDM4EHPGDMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8383843-B2 Method for preparing a coumarin compound, chromene compound, and method for preparing a chromene compound KAOHSIUNG MEDICAL UNIVERSITY (TW) 2013-02-26 US disclosed
US-20120088923-A1 METHOD FOR PREPARING A COUMARIN COMPOUND, CHROMENE COMPOUND, AND METHOD FOR PREPARING A CHROMENE COMPOUND KAOHSIUNG MEDICAL UNIVERSITY (TW) 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088923-A1 METHOD FOR PREPARING A COUMARIN COMPOUND, CHROMENE COMPOUND, AND METHOD FOR PREPARING A CHROMENE COMPOUND CYP3A7, CYP2A7, F7 GPR55 2631/4885ALDH1A1 943/4885KDM4E 3026/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.